Latest Revenue Growth News

Ainsworth Game Technology reported a 10% revenue increase to AUD 290.8 million for 2025 but posted a net loss of AUD 19.2 million, driven by a significant goodwill impairment and foreign currency headwinds. The company’s strategic investments and market challenges set the stage for a pivotal year ahead.

Lumos Diagnostics reported a 74% increase in its half-year loss to US$4.88 million, despite strong progress with its FebriDx diagnostic test and a landmark US distribution agreement. The company awaits a critical FDA decision that could unlock significant revenue growth.

Kina Securities Limited reported a 20% increase in statutory net profit after tax to PGK 120.7 million for 2025, driven by strong revenue growth and loan book expansion. The bank declared a higher final dividend and anticipates continued earnings growth in 2026 amid favourable economic conditions and tax cuts.

Raiz Invest Limited reported a robust half-year performance for the period ending 31 December 2025, with revenue climbing 23.9% and a return to profitability driven by increased customer engagement and funds under management.

Structural Monitoring Systems PLC reported a 31% revenue increase to AUD 16.5 million for H1 2025, driven by strong avionics growth and improved profitability despite ongoing litigation and leadership changes.

Shine Justice Ltd has reported a strong turnaround in its half-year results to December 2025, posting an 8% revenue increase and a return to profitability with a $6.7 million net profit. The legal services firm saw robust growth in personal injury litigation and ongoing class actions, despite cash flow challenges from delayed settlements.

Catalyst Metals Limited delivered a robust half-year result with revenues up 50% and profits rising 40%, driven by higher gold prices and operational advances including a doubling of reserves in the Plutonic Gold Belt.

X2M Connect Limited has secured a $3 million capital raise to fund expansion into new markets and reduce debt, following a robust first half of FY26 marked by significant revenue and profit growth.

Mesoblast Limited reported its first commercial sales of FDA-approved Ryoncil, generating $48.7 million in net product sales for the half-year ended December 31, 2025, while reducing its net loss by 16%. The company also secured a $125 million five-year credit facility, restructuring its debt to support ongoing commercialization and development.

AF Legal Group Limited has reported a robust half-year performance, with revenue climbing 40% to $17.8 million and profits reaching new heights, driven by strategic acquisitions and operational efficiencies.

Weebit Nano Limited has reported a remarkable 8-fold increase in revenue, driven by a landmark licensing agreement with Texas Instruments and significant progress in its ReRAM technology commercialisation.

PEXA Group Limited reported a 10% revenue increase and a 19% rise in EBITDA for the half-year ended December 2025, while announcing its strategic exit from the Digital Solutions segment with a significant loss.